DE69324914D1 - Pharmazeutisches trägersystem, das definierte lipide enthält - Google Patents

Pharmazeutisches trägersystem, das definierte lipide enthält

Info

Publication number
DE69324914D1
DE69324914D1 DE69324914T DE69324914T DE69324914D1 DE 69324914 D1 DE69324914 D1 DE 69324914D1 DE 69324914 T DE69324914 T DE 69324914T DE 69324914 T DE69324914 T DE 69324914T DE 69324914 D1 DE69324914 D1 DE 69324914D1
Authority
DE
Germany
Prior art keywords
pct
carrier system
system containing
pharmaceutical carrier
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69324914T
Other languages
English (en)
Other versions
DE69324914T2 (de
Inventor
Hakan Nyqvist
Gert Ragnarsson
Per Tingvall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipocore Holding Stockholm Se AB
Original Assignee
Pharmacia and Upjohn AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn AB filed Critical Pharmacia and Upjohn AB
Publication of DE69324914D1 publication Critical patent/DE69324914D1/de
Application granted granted Critical
Publication of DE69324914T2 publication Critical patent/DE69324914T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
DE69324914T 1992-03-27 1993-03-26 Pharmazeutisches trägersystem, das definierte lipide enthält Expired - Fee Related DE69324914T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9200952A SE9200952D0 (sv) 1992-03-27 1992-03-27 Pharmaceutical carrier system containing defined lipids
PCT/SE1993/000257 WO1993019736A1 (en) 1992-03-27 1993-03-26 A pharmaceutical carrier system containing defined lipids

Publications (2)

Publication Number Publication Date
DE69324914D1 true DE69324914D1 (de) 1999-06-17
DE69324914T2 DE69324914T2 (de) 1999-12-09

Family

ID=20385758

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69324914T Expired - Fee Related DE69324914T2 (de) 1992-03-27 1993-03-26 Pharmazeutisches trägersystem, das definierte lipide enthält

Country Status (10)

Country Link
US (1) US5635205A (de)
EP (1) EP0636020B1 (de)
JP (1) JPH07508708A (de)
AT (1) ATE179885T1 (de)
DE (1) DE69324914T2 (de)
DK (1) DK0636020T3 (de)
FI (1) FI114140B (de)
NO (1) NO308984B1 (de)
SE (1) SE9200952D0 (de)
WO (1) WO1993019736A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665379A (en) * 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
SE9402453D0 (sv) * 1994-07-12 1994-07-12 Astra Ab New pharmaceutical preparation
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
DE69511418T2 (de) * 1995-10-28 2000-03-30 Braun Melsungen Ag Lokalanästhetika und/oder Zentralanalgetika enthaltende pharmazeutische Zusammensetzungen
WO1998047487A1 (en) * 1997-04-17 1998-10-29 Dumex-Alpharma A/S A novel bioadhesive drug delivery system based on liquid crystals
ATE535232T1 (de) 1997-09-18 2011-12-15 Pacira Pharmaceuticals Inc Retardierte freisetzung liposomaler anesthetischer zusammensetzungen
IL135989A0 (en) 1997-11-14 2001-05-20 Skyepharma Inc Processes for the production of multivesicular liposomes
US6277413B1 (en) 1998-07-17 2001-08-21 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
KR100638150B1 (ko) 1998-12-23 2006-10-26 이데아 악티엔게젤샤프트 생체내에서 국부적인 비침습성 용도로 사용되는 개선된 제제
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
EP1395243A2 (de) * 2001-05-31 2004-03-10 SkyePharma Inc. Verkapselung von nanosuspensionen in liposomen und mikrosphärulen
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
CN102892408A (zh) * 2010-04-01 2013-01-23 帕玛内斯特公司 适于局部麻醉剂的无水药物组合物
IN2014MN02213A (de) 2012-05-10 2015-07-10 Painreform Ltd
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
CA2903020C (en) 2013-02-28 2019-06-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid formulations and its compostions
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3585967D1 (de) * 1984-03-08 1992-06-11 Phares Pharma Holland Liposombildende zusammensetzung.
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
US5059421A (en) * 1985-07-26 1991-10-22 The Liposome Company, Inc. Preparation of targeted liposome systems of a defined size distribution
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system

Also Published As

Publication number Publication date
EP0636020A1 (de) 1995-02-01
SE9200952D0 (sv) 1992-03-27
FI944441A0 (fi) 1994-09-26
US5635205A (en) 1997-06-03
DE69324914T2 (de) 1999-12-09
NO943543L (no) 1994-09-23
NO943543D0 (no) 1994-09-23
ATE179885T1 (de) 1999-05-15
EP0636020B1 (de) 1999-05-12
DK0636020T3 (da) 1999-11-15
JPH07508708A (ja) 1995-09-28
FI114140B (fi) 2004-08-31
NO308984B1 (no) 2000-11-27
WO1993019736A1 (en) 1993-10-14
FI944441A (fi) 1994-09-26

Similar Documents

Publication Publication Date Title
ATE179885T1 (de) Pharmazeutisches trägersystem, das definierte lipide enthält
DK398587D0 (da) Antitumorvirksomt laegemiddel
GR80327B (en) Means for transdermic application of active drug substances
AU640137B2 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
ES2039203T3 (es) Composicion de liposomas.
KR890005088A (ko) 4- 아미노피리딘 유도체 및 그의 산 부가염
KR950028767A (ko) 피부통과 투약을 위한 신규의 약제학적 투여 형태
DK0615443T3 (da) Lægemiddel i akut virksom form indeholdende Flurbiprofen og anvendelse deraf
FR2362849A1 (fr) Nouvelles heterocyclo-omega-pentanorprostaglandines aryliques substituees en position 2 et medicament les contenant
MC1930A1 (fr) Produit antiviral
ES511097A0 (es) "procedimiento para la preparacion de derivados de oxindol".
DE69112573T2 (de) Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält.
SE8302580L (sv) Substituerade iminoderivat av dihydrobensopyran och dihydrobensotiopyran och forfarande for deras framstellning
ES2122962T3 (es) Derivados de alquileno-dioxibenceno opticamente activos y su uso en terapia.
MX9302986A (es) Medicamento que contiene metrifonato y procedimiento para su preparacion
BR9302809A (pt) Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral
FR2681247B1 (fr) Composition pharmaceutique pour application topique contenant du dithranol et procede de preparation.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SCOTIA LIPIDTEKNIK AB, STOCKHOLM, SE

8327 Change in the person/name/address of the patent owner

Owner name: LIPOCORE HOLDING AB, STOCKHOLM, SE

8339 Ceased/non-payment of the annual fee